MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rogers, J. M.
Right arrow Articles by Denison, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rogers, J. M.
Right arrow Articles by Denison, M. S.

Vol. 61, Issue 6, 1393-1403, June 2002

Analysis of the Antiestrogenic Activity of 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Human Ovarian Carcinoma BG-1 Cells

Jane M. Rogers and Michael S. Denison

Department of Environmental Toxicology, University of California, Davis, California

We have used human ovarian carcinoma BG-1 cells to determine which steps in the pathway of estrogen signaling are disrupted by the aryl hydrocarbon receptor (AhR) ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). We report that inhibition of estrogen signaling occurs between 7 and 18 h after TCDD treatment and that this effect is not caused by a decrease in estradiol concentration. TCDD decreased estrogen receptor (ER) levels in cells grown in standard medium; however, in estrogen-stripped medium, ER (but not AhR) levels were dramatically reduced (~7-fold) but were not decreased further by TCDD. Because the absolute level of estradiol inducibility and inhibition by TCDD was similar in either medium, decreases in ER are not responsible for the antiestrogenic effect. The AhR also did not bind to the estrogen-responsive element (ERE) in vitro, and ERE binding by nuclear ER complexes was not decreased by TCDD, indicating that the effect of TCDD does not involve direct competition between the AhR and ER for DNA binding. However, inhibition of protein synthesis by cycloheximide blocked the TCDD-induced inhibition of ER-dependent gene expression. Overall, our results are consistent with the action of a TCDD-induced protein at a step(s) after ER-DNA binding, most likely at the level of gene transcription.

Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. La Merrill, D. S. Baston, M. S. Denison, L. S. Birnbaum, D. Pomp, and D. W. Threadgill
Mouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat
Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E203 - E210.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
D. R. Boverhof, L. D. Burgoon, K. J. Williams, and T. R. Zacharewski
Inhibition of Estrogen-Mediated Uterine Gene Expression Responses by Dioxin
Mol. Pharmacol., January 1, 2008; 73(1): 82 - 93.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
E. Sonneveld, A. Jonas, O. C. Meijer, A. Brouwer, and B. van der Burg
Glucocorticoid-Enhanced Expression of Dioxin Target Genes through Regulation of the Rat Aryl Hydrocarbon Receptor
Toxicol. Sci., October 1, 2007; 99(2): 455 - 469.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
H. M. Korashy, A. Shayeganpour, D. R. Brocks, and A. O.S. El-Kadi
Induction of Cytochrome P450 1A1 by Ketoconazole and Itraconazole but not Fluconazole in Murine and Human Hepatoma Cell Lines
Toxicol. Sci., May 1, 2007; 97(1): 32 - 43.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
S. Hombach-Klonisch, P. Pocar, J. Kauffold, and T. Klonisch
Dioxin Exerts Anti-estrogenic Actions in a Novel Dioxin-Responsive Telomerase-Immortalized Epithelial Cell Line of the Porcine Oviduct (TERT-OPEC)
Toxicol. Sci., April 1, 2006; 90(2): 519 - 528.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
H. M. Korashy and A. O. S. El-Kadi
Regulatory Mechanisms Modulating the Expression of Cytochrome P450 1A1 Gene by Heavy Metals
Toxicol. Sci., November 1, 2005; 88(1): 39 - 51.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. Matthews, B. Wihlen, J. Thomsen, and J.-A. Gustafsson
Aryl Hydrocarbon Receptor-Mediated Transcription: Ligand-Dependent Recruitment of Estrogen Receptor {alpha} to 2,3,7,8-Tetrachlorodibenzo- p-Dioxin-Responsive Promoters
Mol. Cell. Biol., July 1, 2005; 25(13): 5317 - 5328.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
N. Gharavi and A. O. S. El-Kadi
tert-BUTYLHYDROQUINONE IS A NOVEL ARYL HYDROCARBON RECEPTOR LIGAND
Drug Metab. Dispos., March 1, 2005; 33(3): 365 - 372.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D. C. Spink, B. H. Katz, M. M. Hussain, B. T. Pentecost, Z. Cao, and B. C. Spink
Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells
Carcinogenesis, December 1, 2003; 24(12): 1941 - 1950.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics